These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29992636)

  • 1. Association of CD28 and CTLA4 haplotypes with susceptibility to primary Sjögren's syndrome in Mexican population.
    López-Villalobos EF; Carrillo-Ballesteros FJ; Muñoz-Valle JF; Palafox-Sánchez CA; Valle Y; Orozco-Barocio G; Oregon-Romero E
    J Clin Lab Anal; 2019 Jan; 33(1):e22620. PubMed ID: 29992636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of CTLA4 haplotypes on susceptibility and some extraglandular manifestations in primary Sjögren's syndrome.
    Downie-Doyle S; Bayat N; Rischmueller M; Lester S
    Arthritis Rheum; 2006 Aug; 54(8):2434-40. PubMed ID: 16869018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The -319C/+49G/CT60G haplotype of CTLA-4 gene confers susceptibility to rheumatoid arthritis in Mexican population.
    Torres-Carrillo N; Ontiveros-Mercado H; Torres-Carrillo NM; Parra-Rojas I; Rangel-Villalobos H; Ramírez-Dueñas MG; Gutiérrez-Ureña SR; Valle Y; Muñoz-Valle JF
    Cell Biochem Biophys; 2013; 67(3):1217-28. PubMed ID: 23703660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of IL10 haplotypes in primary Sjögren's syndrome patients from Western Mexico: Relationship with mRNA expression, IL-10 soluble levels, and autoantibodies.
    Vázquez-Villamar M; Palafox-Sánchez CA; Muñoz-Valle JF; Valle Y; Orozco-Barocio G; Hernández-Bello J; Oregon-Romero E
    Hum Immunol; 2015 Jul; 76(7):473-9. PubMed ID: 26074416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
    Pawlak-Adamska E; Frydecka I; Bolanowski M; Tomkiewicz A; Jonkisz A; Karabon L; Partyka A; Nowak O; Szalinski M; Daroszewski J
    Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between genetic variants in the tumour necrosis factor/lymphotoxin α/lymphotoxin β locus and primary Sjogren's syndrome in Scandinavian samples.
    Bolstad AI; Le Hellard S; Kristjansdottir G; Vasaitis L; Kvarnström M; Sjöwall C; Johnsen SJ; Eriksson P; Omdal R; Brun JG; Wahren-Herlenius M; Theander E; Syvänen AC; Rönnblom L; Nordmark G; Jonsson R
    Ann Rheum Dis; 2012 Jun; 71(6):981-8. PubMed ID: 22294627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism in the 5' regulatory region of the B-lymphocyte activating factor gene is associated with the Ro/La autoantibody response and serum BAFF levels in primary Sjogren's syndrome.
    Nossent JC; Lester S; Zahra D; Mackay CR; Rischmueller M
    Rheumatology (Oxford); 2008 Sep; 47(9):1311-6. PubMed ID: 18617551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the Genetic Background of Co-Stimulatory CD28/CTLA-4 Pathway the Risk Factor for Prostate Cancer?
    Karabon L; Tupikowski K; Tomkiewicz A; Partyka A; Pawlak-Adamska E; Wojciechowski A; Kolodziej A; Dembowski J; Zdrojowy R; Frydecka I
    Pathol Oncol Res; 2017 Oct; 23(4):837-843. PubMed ID: 28101800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome.
    Nezos A; Papageorgiou A; Fragoulis G; Ioakeimidis D; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M; Mavragani CP
    J Autoimmun; 2014 Jun; 51():89-98. PubMed ID: 23845207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FAS -670A>G promoter polymorphism is associated with soluble Fas levels in primary Sjögren's syndrome.
    Treviño-Talavera BA; Palafox-Sánchez CA; Muñoz-Valle JF; Orozco-Barocio G; Navarro-Hernández RE; Vázquez-Del Mercado M; García de la Torre I; Oregon-Romero E
    Genet Mol Res; 2014 Jul; 13(3):4831-8. PubMed ID: 25062418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of TNFSF4 polymorphisms with susceptibility to primary Sjögren's syndrome and primary biliary cirrhosis in a Chinese Han population.
    Kong F; Li JX; Li P; Li YZ; Zhang FC; Zhang J
    Clin Exp Rheumatol; 2013; 31(4):546-51. PubMed ID: 23622253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD28, CTLA-4 and CCL5 gene polymorphisms in patients with rheumatoid arthritis.
    Luterek-Puszyńska K; Malinowski D; Paradowska-Gorycka A; Safranow K; Pawlik A
    Clin Rheumatol; 2017 May; 36(5):1129-1135. PubMed ID: 27988812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of CD28 IVS3 +17T/C polymorphism with soluble CD28 in rheumatoid arthritis.
    Ledezma-Lozano IY; Padilla-Martínez JJ; Leyva-Torres SD; Parra-Rojas I; Ramírez-Dueñas MG; Pereira-Suárez AL; Rangel-Villalobos H; Ruiz-Quezada SL; Sánchez-Hernández PE; Muñoz-Valle JF
    Dis Markers; 2011; 30(1):25-9. PubMed ID: 21508506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTLA-4 +49A/G and CT60 gene polymorphisms in primary Sjögren syndrome.
    Gottenberg JE; Loiseau P; Azarian M; Chen C; Cagnard N; Hachulla E; Puechal X; Sibilia J; Charron D; Mariette X; Miceli-Richard C
    Arthritis Res Ther; 2007; 9(2):R24. PubMed ID: 17341301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNFSF4 is a risk factor for rheumatoid arthritis but not for primary Sjögren's syndrome in the Mexican population.
    Ramírez-Bello J; Jiménez-Morales S; Barbosa-Cobos RE; Sánchez-Zauco N; Hernández-Molina G; Luria-Pérez R; Fragoso JM; Cabello-Gutiérrez C; Montúfar-Robles I
    Immunobiology; 2022 Jul; 227(4):152244. PubMed ID: 35835012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of functional MBL polymorphisms. Associations with rheumatoid arthritis and primary Sjögren's syndrome.
    Song GG; Bae SC; Seo YH; Kim JH; Choi SJ; Ji JD; Lee YH
    Z Rheumatol; 2014 Sep; 73(7):657-64. PubMed ID: 25060516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression patterns of CD28 and CTLA-4 in early, chronic, and untreated rheumatoid arthritis.
    García-Chagollán M; Ledezma-Lozano IY; Hernández-Bello J; Sánchez-Hernández PE; Gutiérrez-Ureña SR; Muñoz-Valle JF
    J Clin Lab Anal; 2020 May; 34(5):e23188. PubMed ID: 31907973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BLK and BANK1 variants and interactions are associated with susceptibility for primary Sjögren's syndrome and with some clinical features.
    Montúfar-Robles I; Lara-García S; Barbosa-Cobos RE; Vargas-Alarcón G; Hernández-Molina G; Fragoso JM; Cabello-Gutiérrez C; Reyes-Cetina IL; Arenas-Silva I; Cruz-Mayor KJ; Concha-Del Río LE; De Anda-Turati M; Sánchez-Tlapalcoyoatl A; Cheja-Kalb R; Hubbe-Tena C; Lima G; Mendoza-Rincón JF; Ramírez-Bello J
    Cell Immunol; 2021 May; 363():104320. PubMed ID: 33756160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variant form of STAT4 is associated with primary Sjögren's syndrome.
    Korman BD; Alba MI; Le JM; Alevizos I; Smith JA; Nikolov NP; Kastner DL; Remmers EF; Illei GG
    Genes Immun; 2008 Apr; 9(3):267-70. PubMed ID: 18273036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome.
    Gottenberg JE; Sellam J; Ittah M; Lavie F; Proust A; Zouali H; Sordet C; Sibilia J; Kimberly RP; Mariette X; Miceli-Richard C
    Arthritis Res Ther; 2006; 8(1):R30. PubMed ID: 16507129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.